2'-Deoxy-2'-fluorothymidine is a fluorinated nucleoside analog. Its chemical structure is derived from thymidine, with a fluorine atom substituted at the 2' position of the sugar moiety. This modification significantly alters its biochemical properties compared to the natural nucleoside. This compound is a key intermediate in the synthesis of various antiviral and anticancer nucleoside drugs. Most notably, it serves as a crucial precursor in the production of Alovudine (FLT, 3'-Fluoro-3'-deoxythymidine), an antiretroviral drug that was investigated for the treatment of HIV infection. Its mechanism of action, as part of the final drug molecule, involves inhibition of viral reverse transcriptase after intracellular phosphorylation to its active triphosphate form. While primarily recognized for its role in pharmaceutical synthesis, it also finds application as a specialized building block in medicinal chemistry research for developing novel therapeutic agents targeting viral and cellular polymerases.